Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Perceptive and Freenome signed a business merger agreement
10 December 2025

Perceptive and Freenome signed a business merger agreement

Announcement Freenome Holdings, Inc., a leading early cancer detection company establishing blood-related screening tests and Perceptive Capital Solutions Corp, a known special purpose acquisition company (SPAC), presented by a subsidiary of Perceptive Advisors, have signed a definitive business me...

Eli Lilly’s smartly deals with Health Sustainability and Literacy
10 December 2025

Eli Lilly’s smartly deals with Health Sustainability and Literacy

Announcement Eli Lilly, the leading Pharmaceutical company, has been working towards improving and developing the healthcare sector from the core for more than a decade. The company is working to enhance global patient affordability and health literacy while achieving all the sustainability goals....

Aden Duale’s warm welcome to the new partnership framework between Kenya and the USA
10 December 2025

Aden Duale’s warm welcome to the new partnership framework between Kenya and the USA

Announcement The increased concern across the global healthcare sector is seeking acquisition, a strong trading business, or a valuable partnership to improve the specific regional healthcare sector. Latest, Aden Duale, a Health Cabinet Secretary, has excitingly confirmed the partnership framework...

Defence Therapeutics’ new board to navigate ADC Programs
09 December 2025

Defence Therapeutics’ new board to navigate ADC Programs

Announcement Defence Therapeutics Inc., a leading biotechnology company modernising an exclusive intracellular delivery platform that allows more effective, safe and potent radiotherapeutic and antibody-related treatments, has introduced its new Scientific Advisory Board (SAB), involving leaders su...

PreveCeutical crowned for its Innovative Pain Therapy Technology
09 December 2025

PreveCeutical crowned for its Innovative Pain Therapy Technology

Announcement PreveCeutical Medical Inc. is excited to declare its authorisation, as the Australian Patent Office has awarded Australian Patent No. AU2020212659, headlined “A Cyclic Peptide”. This headline is based on the Company’s pain therapy program. This authorisation marks a ...

1910s promising AI model inked in the JCIM
09 December 2025

1910s promising AI model inked in the JCIM

Announcement The first-ever AI-familiar biotech groundbreaking large and small molecule therapeutics discovery, 1910, has proudly announced that its robust AI model, CANDID-CNS™, is now a part of the Journal of Chemical Information and Modeling (JCIM). Being published in an American Chemical ...

Crescent, Kelun-Biotech therapy switch move cost billions
09 December 2025

Crescent, Kelun-Biotech therapy switch move cost billions

Announcement The Massachusetts-based Crescent Biopharma has joined forces with China’s Sichuan Kelun-Biotech to establish and advance the combined antibody-drug conjugate and PD-1/VEGF bispecific, in a collaboration valued at around $1.25 billion. Basically, it’s a swapping of therapie...

BioHarvest Sciences’ new product to accelerate growth in the US Electrolytes Drink Market
08 December 2025

BioHarvest Sciences’ new product to accelerate growth in the US Electrolytes Drink Market

Announcement BioHarvest, a leading company innovating its authorised Botanical Synthesis technology platform, has proudly launched its VINIA Blood Flow Hydration™ for and in the U.S. It’s a first-ever hydration solution sponsored by the blood flow plus points of VINIA’s Piceid res...

Microbiome Labs' new formula, a relief for digestive issues
08 December 2025

Microbiome Labs' new formula, a relief for digestive issues

Announcement Microbiome Labs, a champion in microbiome-related solutions, inaugurated DigestMate™, a probiotic and 2-in-1 digestive enzyme formula. As observed, the digestive health issues have peaked in the American region, affecting an infinite number of lives, and the demand for innovative...

Capricor returns to the FDA’s doorstep for DMD Cardiomyopathy Therapy
08 December 2025

Capricor returns to the FDA’s doorstep for DMD Cardiomyopathy Therapy

Announcement Capricor has again come up with the pivotal results for DMD cardiomyopathy therapy after the rejection. After six months of receiving the shocking rejection for Capricor’s cell therapy deramiocel, which showed a steady decline in cardiac function and a noteworthy benefit in uppe...